For most enterprise applications, vector support is a feature that should be woven into the existing data estate, not a ...

When Oracle began trimming its workforce earlier this year, the immediate impact was visible in job losses across regions and roles. But in the weeks since, a quieter shift has taken hold inside the ...

Why OpenAI’s raise didn’t move markets Nike’s latest stumble—and what’s next Oracle’s 30,000-person layoff 🎧 The Motley Fool Money podcast drops daily after the bell! Listen on Apple Podcasts, ...

Oracle stock rose 6% as the cloud-computing and database company began to reduce its work force. The cuts come as Oracle builds out costly data centers for artificial-intelligence development. The ...

This story has been updated with comments from Related Digital. SALINE TWP., MI — A rural resident is not done fighting to halt construction of the “Stargate” hyperscale data center project that is ...

The rollout includes Aave Pro for advanced users and integrates Chainlink to provide oracle data for V4 markets. Decentralized finance (DeFi) lending platform Aave has launched its V4 protocol on ...

SALINE TWP., MI — Construction of the “Stargate” data center in Saline Township has brought an increase in truck traffic, with some residents and local officials reporting traffic problems. Moving ...

Along with energy stocks, shares of AI-related and chip names were also helping limit losses in the broader market on Wednesday. Shares of Oracle Corp. were popping nearly 11% after the software ...

Oracle (ORCL) reports Q3 earnings after the bell tonight. Shares of the company remain under pressure headed into earnings as Wall Street worries about debt load and the company’s deep ties to OpenAI.

CFO Doug Kehring set the tone early: “Q3 being the first quarter in over 15 years where both organic total revenue and organic non-GAAP EPS grew at 20% or better.” A milestone that immediately ...

Here are the biggest calls on Wall Street on Wednesday: RBC initiates Eli Lilly at outperform RBC says the weight loss pharmaceutical maker is best positioned to fight obesity. "We favor Lilly ( TP $1 ...